NCT02048488
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02048488
Title A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | GBR | ESP

Facility Status City State Zip Country Details
Goodyear Arizona United States Details
Scottsdale Arizona United States Details
Los Angeles California United States Details
Nashville Tennessee United States Details
Norfolk Virginia United States Details
Spokane Washington United States Details
Poznan Greater Poland Voivodeship Poland Details
Warsaw Masovian Voivodeship Poland Details
Gdansk Pomeranian Voivodeship Poland Details
Olsztyn Warmian-Masurian Voivodeship Poland Details
Madrid Spain Details
Santiago de Compostela Spain Details
Tainan Taiwan Details
Taipei Taiwan Details
London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field